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ABSTRACT
Objective: Hospital admission records provide
snapshots of clinical histories for a subset of the
population admitted to hospital. In contrast, primary
care records provide continuous clinical histories for
complete populations, but might lack detail about
inpatient stays. Therefore, combining primary and
secondary care records should improve the ability of
comorbidity scores to predict survival in population-
based studies, and provide better adjustment for case-
mix differences when assessing mortality outcomes.
Design: Cohort study.
Setting: English primary and secondary care
1 January 2005 to 1 January 2010.
Participants: All patients 20 years and older
registered to a primary care practice contributing to the
linked Clinical Practice Research Datalink from England.
Outcome: The performance of the Charlson index
with mortality was compared when derived from either
primary or secondary care data or both. This was
assessed in relation to short-term and long-term
survival, age, consultation rate, and specific acute and
chronic diseases.
Results: 657 264 people were followed up from
1 January 2005. Although primary care recorded more
comorbidity than secondary care, the resulting C
statistics for the Charlson index remained similar: 0.86
and 0.87, respectively. Higher consultation rates and
restricted age bands reduced the performance of the
Charlson index, but the index’s excellent performance
persisted over longer follow-up; the C statistic was
0.87 over 1 year, and 0.85 over all 5 years of follow-
up. The Charlson index derived from secondary care
comorbidity had a greater effect than primary care
comorbidity in reducing the association of upper
gastrointestinal bleeding with mortality. However, they
had a similar effect in reducing the association of
diabetes with mortality.
Conclusions: These findings support the use of the
Charlson index from linked data and show that
secondary care comorbidity coding performed at least
as well as that derived from primary care in predicting
survival.
INTRODUCTION
Comparisons of outcomes from hospitals fre-
quently use the comorbidity data recorded
during a hospital admission to adjust for differ-
ences in case mix.1–4 However, secondary care
admissions provide only snapshots of a patient’s
clinical journey and might not contain compre-
hensive information on chronic conditions. In
contrast, primary care data records a longitu-
dinal picture of a patient’s clinical journey, but
some events managed directly in secondary
care might be missed. Previous work provides
evidence to support this hypothesis by showing
that primary care data increased the sensitivity
of detecting diagnoses (eg, diabetes, cirrhosis,
acute coronary syndrome and upper gastro-
intestinal bleeding), while secondary care data
identiﬁed cases with a higher mortality.5–8
Combining primary and secondary data care
might therefore provide a better adjustment
for differences in case mix than data from
single clinical settings.
Strengths and limitations of this study
▪ Large population-based study using linked
primary care, secondary care and national death
register data to provide complete longitudinal
health records.
▪ Detailed stratified assessment of the performance
of the Charlson index with 5 years of follow-up,
including the effect of the consultation rate.
▪ Comparison of primary and secondary care
comorbidity data in adjusting for case mix in sur-
vival analyses, and the benefits of linking the two.
▪ Large routine data sets might have misclassifica-
tion errors in coding. While data cleaning and
audits confirm overall accuracy, it is not possible
to directly validate Hospital Episodes Statistics
coding due to its anonymisation prior to
research use.
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One common example of a secondary care-derived
comorbidity score used to adjust for case-mix differences
is the Charlson index. It was originally derived in 1987
using a secondary care cohort of just 559 medical admis-
sions with 1 year of follow-up for death, and it was vali-
dated in only 685 patients with breast cancer.9 Yet,
despite the small number of patients and the passage of
time, the Charlson index remains the most widely vali-
dated and used comorbidity score in research.10 What is
not clear, however, is whether the Charlson index per-
forms equally well in primary and secondary care data
over both the short (1 year) and longer term (up to
5 years), and whether combining information from both
sources would provide a better measure of comorbidity.
With the recent linkage between primary and secondary
care records in England, and the additional linkage to
the Ofﬁce for National Statistics death register, there is
now an opportunity to assess the performance of the
Charlson index in these different clinical settings while
using the same underlying population cohort.
In this study, we aim to assess the performance of
the Charlson index derived from either primary or sec-
ondary care data or both. We will assess how changing
the parameters that were used to deﬁne the comorbid-
ities for the Charlson index affects its performance,
and how the Charlson index interacts with patients’
age, socioeconomic status and consultation rates.
The performance will be assessed with regard to dis-
crimination in predicting short-term and long-term
mortality and adjusting for case mix. For the latter, we
will assess the association of both a chronic diagnosis
of diabetes and an acute secondary care diagnosis of
acute upper gastrointestinal bleeding with mortality, by
adjusting for comorbidity deﬁned by the Charlson
index derived from its coding in either primary or sec-
ondary care.
METHODS
Data source
A cohort study was designed using linked longitudinal
data from the linked English Hospital Episodes Statistics
(HES) data, Clinical Practice Research Datalink (CPRD)
and Ofﬁce of National Statistics (ONS) death register.
These data have linked records of all primary care
events, hospital admissions and causes of death from 1
April 1997 to 31 December 2010 for 3% of the English
population. Owing to the comprehensive English
primary care system, the population registered to each
practice contributing to the CPRD is broadly representa-
tive of the general English population, but there is some
under-representation of teenagers and young adults who
are generally more mobile and registered as temporary
patients.11 The data sources are subject to quality
checks, and a practice’s data are only used when they
are of high enough quality to be used in research. This
is referred to as the up to research standard time period
and is deﬁned separately for each primary care practice.
Study population
We selected all adults older than 20 years in the CPRD
on 1 January 2005 who were registered at a practice that
continued contributing to the CPRD until 1 January
2010, and had consented to linkage with HES and ONS.
These patients were followed up until the earliest of date
of death, the date a patient’s care was transferred out of
a CPRD practice or the last date of the study (1 January
2006 or 1 January 2010, depending on the analysis).
Exposures
The main exposure of interest for the study was the
Charlson index (table 1). This was calculated three
times for each person using: (1) Read codes recorded in
primary care, (2) International Classiﬁcation of Diseases
(ICD) 10 codes recorded in secondary care and (3) by
combining both the Read and ICD10 codes. Diagnostic
codes were only included prior to 1 November 2004 in
order to exclude codes that might have been directly
related to terminal events in the initial follow-up period.
The original derivation of the Charlson index was scaled
so that a single point increase in the score was equiva-
lent to a reduction in survival by a decade.9 We there-
fore grouped all scores greater than 5 (as in the original
paper), because differentiating between reductions in
survival greater than 50 years was not judged to be
useful. We used the ICD10 codes previously published
by Quan et al12 and the Read codes were adapted from
the Read and Oxmis code lists of Khan et al.13
Other exposures of interest included age (in 10-year
age bands), gender, primary care consultation rate (cate-
gorised into 0, 1, 2–3, 4–7, 8–13, ≥14 primary care
face-to-face consultations a year), socioeconomic quin-
tiles deﬁned by Indices of Multiple Deprivation for
Table 1 Comorbidities contributing to the original
Charlson index
Comorbidity Weighting
Myocardial infarct 1
Congestive heart failure 1
Peripheral vascular disease 1
Cerebrovascular disease 1
Dementia 1
Connective tissue disease 1
Chronic pulmonary disease 1
Ulcer disease 1
Mild liver disease 1
Diabetes 1
Hemiplegia 2
Moderate or severe renal disease 2
Diabetes with end-organ damage 2
Any tumour 2
Leukaemia 2
Lymphoma 2
Moderate or severe liver disease 3
Metastatic solid tumour 6
HIV 6
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England 2007,14 and hospitalisation in the previous year
deﬁned by a recorded admission in secondary care data
(excluding the 60 days prior to the study start date).
Outcome
The outcome of the study was all-cause mortality. The
date and fact of death were obtained from the linked
Ofﬁce for National Statistics data.
Analysis
The proportion of the study population with a Charlson
index greater than zero was calculated. Cox proportional
hazard models predicting survival up to 1 year were then
ﬁtted for each derivation of the Charlson index. Age
and gender were included as a priori confounders in
the models. The interaction of the Charlson index was
tested (using likelihood ratio tests) with age, socio-
economic status and consultation rate. The follow-up
time was then extended to 5 years, and the model strati-
ﬁed by follow-up time (<1, 1–2, 2–3, 3–4, 4–5 years).
To compare goodness-of-ﬁt between the different
models, we used Akaike’s Information Criterion which
penalises the likelihood for model complexity.
Likelihood ratio testing cannot be used, as models with
the different Charlson index derivations are not nested
within each other. To assess the discriminative ability of
each of the Charlson indexes in relation to survival, we
derived Harrell’s C statistic.15 This was calculated for
each derivation of the Charlson index, and then strati-
ﬁed for the different follow-up times, ages, socio-
economic quintiles and consultation rates described
above. CIs for C statistics and differences were calculated
from jackknife variance estimates.16
We performed three sensitivity analyses. First, to assess
the effect of only using recently recorded comorbidity, we
derived the Charlson index from either comorbidity
recorded only in the year prior to the study, or comorbid-
ity recorded more than 1 year prior to the study. Second,
to assess the effect of potentially including codes related
to palliative end-of-life processes, we excluded patients
with less than 1, 3, or 6 months of follow-up after the
study start date. Finally, it has been shown that recording
of prevalent diagnoses can take up to 1 year following
registration with a primary care doctor.17 We therefore
repeated the analysis excluding patients with less than
1 year of data prior to the start date of the study.
Performance of the Charlson index in adjusting for
comorbidity in diabetes and upper gastrointestinal
bleeding
The extent to which the Charlson index reduces the
direct effect of an association with mortality is a measure
of the extent it adjusts for the indirect effect of
comorbidity. We selected two diseases as examples for
which this is plausible; diabetes, which is a disease that
increases the risk of many other comorbidities that
indirectly reduce survival,18 19 and upper gastrointes-
tinal bleeding, which is an acute event in which
comorbidity both predicts its occurrence and its subse-
quent mortality.20–22 We used a Cox proportional
hazards model adjusted for age and gender to compare
the ability of each of the Charlson index derivations to
adjust for the effect of comorbidity on 1-year survival.
For the analysis of diabetes, we removed the category of
diabetes from the calculation of the Charlson index to
avoid duplicating its coefﬁcient in the model.
For a chronic disease such as diabetes, the diagnosis
date does not necessarily indicate disease onset; there-
fore, for this analysis, we selected all patients with a
recording of diabetes prior to November 2004, and fol-
lowed them up from 1 January 2005 (using the same
deﬁnition as when deﬁning the Charlson index). This
cohort was compared with all patients without a record-
ing of diabetes prior to November 2004 and followed up
from 1 January 2005.
In contrast, upper gastrointestinal bleeding is an acute
event with a deﬁned date of onset. We therefore fol-
lowed up all patients with a ﬁrst recorded bleed in our
cohort from the date of bleed using a method we pub-
lished previously.6 For the comparison cohort of patients
without upper gastrointestinal bleeding, we followed up
from a random observed date. The Charlson index was
recalculated on either the date of bleed or a random
observed date for the bleed and non-bleed patients,
respectively.
All analyses were performed using Stata V.13.
RESULTS
Study population
A total of 657 264 people were followed up from 1
January 2005 until 1 January 2006, or 1 January 2010,
depending on the analysis. In the ﬁrst year of follow-up,
there were 21 672 deaths during 216 million days, with
an average follow-up of 329 days/person. For the
extended follow-up to 2010, there were 95 596 deaths in
1.9 million years with an average follow-up of 2.9 years/
person. The age structure of the population was similar
to that of the UK population (table 2), as would be
expected from a national population database.11
Recording of the Charlson index comorbidity in primary
and secondary care
Table 2 shows the proportion of the population with a
Charlson index greater than zero when derived from
either a single data set or from both. Read codes from
primary care identiﬁed almost three times the number
of people with a Charlson index greater than zero com-
pared to when the Charlson index was derived from hos-
pital admission ICD codes. When examined in more
detail, the primary care data identiﬁed more of each
Charlson index comorbidity than did secondary care
data, apart from metastatic cancer and hemiplegia (see
online supplementary table A). Thirty per cent of
people had a Charlson index greater than zero when
the information from both data sets was combined.
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Fit and performance of the Charlson index in predicting
mortality
Age contributed the most to an improvement in both
goodness-of-ﬁt and discrimination of the Cox propor-
tional hazards model (table 3). There was a better
goodness-of-ﬁt when the Charlson index was derived
from secondary care ICD10 codes than when it was
derived from primary care Read codes. However, the
slight improvement of using ICD10 codes over Read
codes was reduced when an indicator variable was
included for a recent hospitalisation in the Read code
only version.
There was no large difference in the discrimination of
the model for overall survival, whichever codes were
used to derive the Charlson index: Read codes from
primary care (Harrell’s C statistic 0.86), ICD10 codes
from secondary care (C statistic 0.87), or both Read and
ICD10 codes (C statistic 0.87). Including a marker for a
recent hospital admission resulted in a slightly improved
discrimination for each Charlson derivation (p<0.0001).
Stratified analysis of the fit and performance of the
Charlson index in predicting mortality
There was a signiﬁcant interaction between age group
and Charlson index (likelihood ratio test p<0.0001) with
the model’s discrimination reducing with age. Each
Charlson index derivation had a good discrimination for
each of the 10-year age bands younger than 70 years, fair
discrimination for each of the 10-year age bands up to
90 years, but was poor at discriminating for those who
were older (table 4). The Charlson index derived from
ICD10 or both data sources showed small but signiﬁcant
improvements (p<0.0001) in discrimination within the
age bands older than 50 years, when compared with the
primary care-derived Charlson index.
There was also a signiﬁcant interaction with the con-
sultation rate (likelihood ratio test p<0.0001) with excel-
lent discrimination of each Charlson index derivation
when the number of consultations in the prior year was
below 14, and good discrimination above 14 consulta-
tions in the prior year (table 4). The Charlson index
derived from ICD10 or both data sources showed small
but signiﬁcant improvements in discrimination
(p<0.0001) within the strata with more than four consul-
tations per year when compared with the primary care-
derived Charlson index. There was a weak interaction
with socioeconomic status (p=0.01), but when stratiﬁed,
the variation was minimal with no clear trends (see
online supplementary table B).
Finally, we assessed the performance of each Charlson
index derivation during each year of follow-up.
The C statistic remained excellent for both primary and
secondary care up to 5 years of follow-up, with a slight
reduction from 0.87 in the ﬁrst year to 0.82 in the ﬁfth
year (table 4 combined primary and secondary care).
There were very small but still signiﬁcant improvements
in discrimination (p<0.0001) when using either the
Charlson index derived from ICD10 or both data
sources. Over all 5 years of follow-up, the combined
Charlson index had a C statistic of 0.85.
Sensitivity analyses
Restricting comorbidity to that recorded only in the year
prior to the study (2004) reduced the overall C statistic
Table 2 Demographics of the study population, England, 2005–2010
Number of people Percentage of total
Age group (years)
20–29 136 464 21.34
30–39 136 464 20.76
40–49 92 744 14.11
50–59 74 659 11.36
60–69 61 373 9.34
70–79 64 470 9.81
80–89 67 004 10.19
≥90 20 267 3.08
Gender
Male 328 382 49.96
Female 328 882 50.04
Charlson
index score
Derived from
Read codes (n) (%)
Derived from
ICD10 codes (n) (%)
Derived from
combined codes (n) (%)
0 467 501 71.13 573 047 87.19 456 681 69.48
1 111 178 16.92 42 660 6.49 110 692 16.84
2 42 246 6.43 21 816 3.32 42 579 6.48
3 19 680 2.99 8619 1.31 21 641 3.29
4 8406 1.28 4109 0.63 10 574 1.61
≥5 8253 1.26 7013 1.07 15 097 2.30
ICD, International Classification of Diseases.
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Table 3 Performance and goodness-of-fit of different proportional hazard models predicting mortality using different
demographics and derivations of the Charlson index, England, 2005–2010
Model covariates C statistic 95% CI
Difference in C statistic
from previous row* AIC
Gender only 0.513 (0.509 to 0.516) – 576 065
Age and gender 0.844 (0.842 to 0.846) 0.332 (0.328 to 0.335) 538 291
Age, gender, and Read-derived Charlson index 0.861 (0.859 to 0.863) 0.016 (0.016 to 0.017) 534 185
Age, gender, recent hospitalisation and
Read-derived Charlson index
0.868 (0.866 to 0.869) 0.0069 (0.0063 to 0.0074) 532 176
Age, gender and ICD10-derived Charlson index 0.870 (0.868 to 0.872) 0.0026 (0.0018 to 0.0034) 531 085
Age, gender, recent hospitalisation and
ICD10-derived Charlson index
0.872 (0.871 to 0.874) 0.0021 (0.0018 to 0.0024) 530 318
Age, gender and combined ICD10 and
Read-derived Charlson index
0.869 (0.869 to 0.870) −0.0039 (−0.0046 to −0.0031) 531 830
Age, gender, recent hospitalisation and combined
ICD10 and Read-derived Charlson index
0.873 (0.871 to 0.874) 0.0040 (0.0036 to 0.0044) 530 469
The smaller the AIC value, the better the goodness-of-fit with less information loss.
*All differences in C statistic in this column had a p value <0.0001.
AIC, Akaike’s Information Criterion; ICD, International Classification of Diseases.
Table 4 The discrimination of Charlson index in predicting mortality stratified by age, follow-up and consultation rate,
England, 2005–2010
Age (years)
Number of
people (%)
C statistic adjusted for recent hospitalisation, gender and Charlson
index derived from
Read
(95% CIs) ICD10 ICD10 and Read
20–29 140 283 21 0.71 (0.66 to 0.75) 0.71 (0.67 to 0.76) 0.71 (0.67 to 0.76)
30–39 136 464 21 0.72 (0.69 to 0.76) 0.72 (0.69 to 0.75) 0.74 (0.70 to 0.77)
40–49 92 744 14 0.73 (0.71 to 0.75) 0.72 (0.70 to 0.75) 0.74 (0.72 to 0.76)
50–59 74 659 11 0.75 (0.74 to 0.76) 0.75 (0.73 to 0.76) 0.77* (0.75 to 0.78)
60–69 61 373 9 0.72 (0.71 to 0.73) 0.71 (0.69 to 0.72) 0.73* (0.72 to 0.74)
70–79 64 470 10 0.66 (0.65 to 0.66) 0.67* (0.66 to 0.67) 0.67 (0.66 to 0.68)
80–89 67 004 10 0.62 (0.61 to 0.62) 0.63* (0.63 to 0.64) 0.63 (0.63 to 0.64)
≥90 20 267 3 0.57 (0.56 to 0.58) 0.58* (0.57 to 0.59) 0.58 (0.57 to 0.59)
Consultations
per year (n)
Number of
people (%)
C statistic adjusted for age, recent hospitalisation, gender and
Charlson index derived from
Read ICD10 ICD10 and Read
0 139 457 21 0.87 (0.86 to 0.88) 0.88 (0.86 to 0.89) 0.87 (0.86 to 0.89)
1 70 216 11 0.90 (0.89 to 0.91) 0.90 (0.89 to 0.91) 0.90 0.89 to 0.91)
2–3 105 686 16 0.90 (0.89 to 0.90) 0.90 (0.89 to 0.91) 0.90 (0.89 to 0.91)
4–7 134 415 20 0.86 (0.86 to 0.87) 0.87* (0.86 to 0.87) 0.87 (0.86 to 0.87)
8–13 102 553 16 0.80 (0.80 to 0.81) 0.81* (0.81 to 0.82) 0.81 (0.81 to 0.82)
≥14 104 937 16 0.72 (0.71 to 0.72) 0.74* (0.73 to 0.74) 0.73 (0.73 to 0.74)
Year of
follow-up
Number of
people
Follow-up
(years)
C statistic adjusted for age, recent hospitalisation, gender and
Charlson index derived from:
Read ICD10 ICD10 and Read
0–1 657 264 590 375 0.87 (0.87 to 0.87) 0.87* (0.87 to 0.87) 0.87 (0.87 to 0.87)
1–2 527 516 469 662 0.85 (0.85 to 0.85) 0.85* (0.85 to 0.85) 0.85* (0.85 to 0.85)
2–3 413 085 360 469 0.83 (0.83 to 0.84) 0.84 (0.83 to 0.84) 0.84* (0.83 to 0.84)
3–4 311 556 266 840 0.82 (0.82 to 0.83) 0.82 (0.82 to 0.83) 0.83* (0.82 to 0.83)
4–5 226 541 190 162 0.81 (0.81 to 0.81) 0.81 (0.81 to 0.81) 0.81* (0.81 to 0.81)
*p<0.0001 for difference in C statistic from previous column.
ICD, International Classification of Diseases.
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for the combined index to 0.84, and excluding
comorbidity recorded in that year also reduced it to
0.84. Excluding patients with limited follow-up had a
minimal effect on discrimination of the combined index
(C statistic 0.87 for excluding 1 month and 0.86 for
excluding 3 or 6 months). Finally, excluding patients
who had less than 1 year of follow-up from their registra-
tion date prior to the start of the study did not alter the
discrimination of the model (C statistic 0.87).
Performance of the Charlson index in adjusting for
comorbidity in diabetes and upper gastrointestinal bleeding
The effect of an upper gastrointestinal bleeding event or
a chronic diagnosis of diabetes on all-cause mortality is
shown in table 5 adjusted for the different derivations of
the Charlson index. The derivation from ICD10 or Read
codes had the same effect in reducing the direct associ-
ation of diabetes with mortality. Combining the ICD10
and Read codes did have a greater effect, but the CIs
overlapped with estimates for the separate derivations.
In contrast, for upper gastrointestinal bleeding, the
ICD10 codes on their own had a greater effect than Read
codes in reducing the direct association with mortality.
However, when a ﬂag for a recent hospitalisation was
included, the effect of the Read code-derived Charlson
index became comparable with that derived from ICD10
codes. A ﬂag for a recent hospitalisation was signiﬁcantly
associated with an improvement in model ﬁt with both
bleeding and diabetes independently of the Charlson
index derived from either ICD10 and Read codes (likeli-
hood ratio test for both: p<0.0001).
DISCUSSION
The primary and secondary care-derived Charlson
comorbidity index had good discrimination for both
short-term and long-term survival, with a C statistic of
0.87 in the ﬁrst year and 0.85 for all 5 years. However,
while comorbidity recorded in primary care identiﬁed
almost three times the burden of comorbidity compared
to the diagnoses recorded in secondary care, this did
not produce the expected improvements in discrimin-
ation for overall survival modelling or case mix adjust-
ment. Diagnoses recorded in secondary care actually
showed a slight improvement in goodness-of-ﬁt com-
pared to that in primary care alone, but this was mostly
comparable with the inclusion of a ﬂag for a recent hos-
pitalisation regardless of the reason for admission. This
indicates that life-limiting comorbidity is more likely to
result in a hospital admission and therefore be coded in
secondary care, compared to comorbidity recorded
solely in primary care.
We found larger differences in the performance of the
Charlson index derivations when adjusting for
comorbidity-associated mortality in speciﬁc disease situa-
tions. Upper gastrointestinal bleeding is diagnosed and
managed in secondary care,23 and we found that
comorbidity coding in secondary care or a ﬂag for hospital
admission had a greater effect in adjusting for
comorbidity-associated mortality than primary care Read
codes alone. In contrast, diabetes is a chronic disease that
may be diagnosed and managed in primary care, and we
found that comorbidity coding in primary care had the
same effect on adjusting for comorbidity-associated mor-
tality as secondary care comorbidity coding.
The strength of this study is its size and reﬂection of
real-life practice and coding. This has allowed us to
examine the performance of the Charlson index in rela-
tion to mortality in far more detail than has previously
been possible, providing much needed information on
its practical use, particularly regarding the timing of
included codes to which we found the Charlson index
was reassuringly robust. In addition, our study has exam-
ined the Charlson index separately for each year over an
Table 5 HRs for the effect of a first upper gastrointestinal bleed or a diagnosis of diabetes on 1 year mortality, England,
2005–2010
Model covariates Adjusted HR 95% CI
Upper gastrointestinal bleeding
Age and gender only 5.34 (5.19 to 5.57)
Age, gender and Read-derived Charlson index 4.45 (4.30 to 4.61)
Age, gender, recent hospitalisation and Read-derived Charlson index 4.18 (4.03 to 4.32)
Age, gender and ICD10-derived Charlson index 3.99 (3.85 to 4.13)
Age, gender, recent hospitalisation and ICD10-derived Charlson index 3.90 (3.76 to 4.03)
Age, gender and Combined ICD10 and Read-derived Charlson index 4.11 (3.97 to 4.25)
Age, gender, recent hospitalisation and combined ICD10 and Read-derived Charlson index 3.94 (3.80 to 4.08)
Diabetes
Age and gender only 1.34 (1.29 to 1.40)
Age, gender and Read-derived Charlson index 1.18 (1.14 to 1.23)
Age, gender, recent hospitalisation and Read-derived Charlson index 1.14 (1.10 to 1.18)
Age, gender and ICD10-derived Charlson index 1.15 (1.11 to 1.19)
Age, gender and combined ICD10 and Read-derived Charlson index 1.13 (1.09 to 1.18)
Age, gender, recent hospitalisation and combined ICD10 and Read-derived Charlson index 1.10 (1.06 to 1.15)
ICD, International Classification of Diseases.
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extended period of follow-up and therefore provided
useful evidence supporting the validity of using the
index for longer time periods.
Our study does share the same potential weaknesses
of any study using routine data. While its large size
reduces the risk of random error, there might be
another potential bias in the recording of routine data
through the selection of the population. However, by
using a population-based database from the deﬁned
patient population registered to CPRD practices, any
selection bias would be limited to issues with access to
primary care. As England has universal coverage of
primary care registration, this bias should therefore be
minimal. By contrast, any bias related to diagnosis mis-
coding is more critical, and one of the limitations of
routine data is that their anonymisation prevents the
large-scale validation of individual records against the
original clinical chart records. Although this potentially
leaves the databases susceptible to accusations of poor
coding quality,24 25 the HES data submissions are regu-
larly cleaned and monitored for data quality and consist-
ency. An in-depth government audit of samples of UK
hospital data conﬁrmed that there was an accuracy in
recording that approached 90%.26 Similarly, CPRD
primary care records undergo regular quality and
consistency checks, and a practice’s data is only included
when it is of high enough quality to be used in research
(at these times, the data are said to be ‘up to standard’).27
The CPRD has been extensively validated with paper
records for a wide range of diagnoses with a mean posi-
tive predictive value of 89%.28 The use of these routine
data in research is therefore unsurprisingly considered
valid in the numerous studies that utilise them.
Furthermore, there is no other practical method to
achieve the same scale, generalisability and efﬁciency in
research that using routine healthcare records provides.
Previous studies have shown that using linked primary
and secondary care data improved the identiﬁcation of a
limited number of diseases compared to using unlinked
data sources. Speciﬁcally, it increased the sensitivity of
identifying chronic diseases such as diabetes,8 29 cirrho-
sis,7 venous thromboembolic events,30 acute myocardial
infarction5 and acute upper gastrointestinal bleeding.6
In contrast, using only primary care data reduced the
severity of the diagnoses identiﬁed, and missed identify-
ing more severe cases found only in hospital data.6 7 31
Our study has now been able to generalise these previ-
ous ﬁndings by showing that primary care data do iden-
tify a greater proportion of patients with comorbidity,
but that they had a lower burden of comorbidity than
patients identiﬁed in secondary care data. The inclusion
of this additional comorbidity from primary care did not
therefore have a large effect on model performance.
A few other studies, including the one by the original
author, have validated the Charlson index in discriminat-
ing survival for longer time periods.9 13 32 33 However,
these studies have important limitations; such as only
using primary or secondary care data, restricting to
patients with cancer or the elderly,9 13 32 or using
methods that do not take account of censoring in
routine data. Most other studies have only used inpatient
mortality or 1-year mortality.34 In contrast, our study has
been able to examine in detail the performance of the
Charlson index in discriminating survival over 5 years of
follow-up.
Two papers from Medicare data found no difference
in discrimination from using inpatient or outpatient
claims data to derive the Charlson index for predicting
mortality. Zhang et al35 found that the choice of source
data or time span used did not alter the discrimination
for 2-year survival (C statistic=0.70). Li et al36 found that
excluding outpatient claims data from the Charlson
index did not alter discrimination for 6-month survival
(C statistic=0.74). This contrasts with our study, but
reﬂects the effect of restricting to an older population
who had all been recently hospitalised.
A patient’s presentation to healthcare of one condi-
tion increases the likelihood that other diagnoses will be
identiﬁed. Therefore, one potential problem of
comorbidity scores in routine data is that a comorbidity
score might be a marker of patients who visit their
doctors frequently.33 In this study, we have demonstrated
that the Charlson index predicted mortality independ-
ently of consultation rates, and with excellent discrimin-
ation, albeit with a reduction to good among patients
who visited their doctor more than 14 times in a year.
However, this was because a greater proportion of
patients with higher consultation rates had serious or
multimorbidity, and this reduced the ability of the
Charlson index to discriminate between the patients.
A previous study found that increasing the observation
period from which the Charlson index was calculated
increased the sensitivity of the detection of comorbidity,
but that the speciﬁcity remained the same.37 In our
study, restricting to or excluding the year prior to the
study in the calculation of the Charlson index reduced
the discrimination as measured by the C statistic.
In all our models, age remained the biggest predictor
of mortality. This is because age remains an accurate,
comprehensive and objectively recorded variable in
routine data that is strongly associated with the risk of
death. In contrast, comorbidity scores in routine data
attempt to simplify what will always be a complicated
and imprecise clinical assessment in a restrictive coding
structure.10 31 However, in our study, the Charlson index
still provided signiﬁcant additional improvements in
model discrimination, and also measurable improve-
ments in performance when adjusting mortality for
comorbidity as shown in the disease-speciﬁc examples of
upper gastrointestinal bleeding and diabetes.
In conclusion, our study demonstrates good perform-
ance of the Charlson index using linked primary and
secondary care data to classify risk of death at 1 year and
for longer periods up to 5 years. We found that primary
care data identiﬁed a higher prevalence of comorbidity
than secondary care, but this did not result in improved
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performance or discrimination. The inclusion of a
marker for recent hospitalisation made the data sources
more comparable, but combining the data sources did
not result in the expected improvement in the ability of
the Charlson index to predict survival and adjust for
case mix.
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